Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixe...
Q3 2026
May 15, 2026
Q2 2026
Feb 13, 2026
Q1 2026
Nov 14, 2025
FY 2025
Sep 29, 2025
Q4 2025